Cary J. Claiborne - Aug 18, 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Executive Officer
Signature
/s/ Cary J. Claiborne
Stock symbol
ADIL
Transactions as of
Aug 18, 2022
Transactions value $
$0
Form type
4
Date filed
8/22/2022, 04:42 PM
Previous filing
Jul 28, 2022
Next filing
Sep 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADIL Common Stock Award $0 +1M $0.00 1M Aug 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are Restricted Stock Units that vest monthly pro rata over the next 36 months.